Immunodeficiency Type 16

Immunodeficiency type 16 is a very rare inherited problem of the immune system. Doctors also call it “immunodeficiency-16” or “IMD16.” It is a primary immunodeficiency, which means the person is born with a problem in a gene that is important for immune defense. In this condition, there is a harmful change (mutation) in a gene called TNFRSF4, which makes a protein called OX40 on the surface of some white blood cells (T cells). When OX40 does not work, T cells cannot become strong “memory” cells, and B cells (antibody-producing cells) also do not mature normally. Because of this, the body cannot remember germs well and cannot fight some infections properly.

This disease is described as a combined T-cell and B-cell immunodeficiency, meaning both major arms of the adaptive immune system are weak. Children with this condition have a strong tendency to develop childhood-onset Kaposi sarcoma, a type of cancer caused by human herpesvirus 8 (HHV-8). They may also have other infections because their immune system cannot give normal “recall” responses when the body meets a germ again. The condition usually shows up in childhood, and it is inherited in an autosomal recessive way, which means a child needs to receive the faulty gene from both parents.

Immunodeficiency type 16 (IMD16) is a very rare, inherited immune system disease caused by harmful changes in a gene called TNFRSF4, which makes the OX40 protein on activated T-cells. When OX40 does not work, T-cells cannot “remember” infections properly, and the body cannot control certain viruses, especially human herpesvirus-8 (HHV-8). Children with IMD16 can develop severe or early-onset Kaposi sarcoma and have repeated or unusual infections. It is passed in an autosomal recessive way, which means both parents usually carry one silent copy of the gene change. [1]

Because IMD16 is so rare, there are no large clinical trials. Doctors use treatment plans based on general guidelines for combined immunodeficiency and for Kaposi sarcoma, then adapt them to each child. Core care includes infection prevention, immunoglobulin replacement, careful use of antibiotics and antivirals, and sometimes chemotherapy or stem cell transplant in specialist centers. [2] [3]

Because immunodeficiency type 16 is so rare, almost all information comes from a small number of families described in medical reports. In these reports, doctors found that the children had aggressive and widespread Kaposi sarcoma along with clear laboratory signs of poor T-cell memory and fewer circulating memory B cells. This pattern helped them link the disease to loss of OX40 function.

Another names

Doctors and scientists use several different names for immunodeficiency type 16. All of these names describe the same condition, but they focus on different aspects of the disease. One group of names highlights the gene problem, so they say “OX40 deficiency” or “TNFRSF4-related immunodeficiency.” Another group of names focuses on the type of immune problem, such as “combined immunodeficiency due to OX40 deficiency” or simply “combined immunodeficiency 16 (IMD16).”

Other medical names emphasize the link with Kaposi sarcoma and the virus that causes it. In disease databases, the condition is also called “combined immunodeficiency with childhood-onset Kaposi sarcoma” and “combined immunodeficiency with impaired immunity to HHV-8 (human herpesvirus 8).” All of these labels remind doctors that children with this gene defect are especially at risk for Kaposi sarcoma driven by HHV-8 infection.

Types

There is only one main genetic disease called immunodeficiency type 16, but doctors can see slightly different clinical patterns. These are not strict official subtypes, but they can help explain how the disease may appear.

1. Classic childhood Kaposi sarcoma pattern
   In this pattern, a child presents with typical Kaposi sarcoma skin spots or nodules at a young age, often before doctors know there is an immune problem. Later tests show combined T- and B-cell weakness and the gene mutation in TNFRSF4. This is the most clearly described pattern in medical reports.

2. Infection-dominant pattern
   Some patients may first show repeated or severe infections, especially viral infections, before the tumor is recognized. They may have poor vaccine responses or repeated respiratory infections. Kaposi sarcoma may come later, but the main early sign is a general picture of combined immunodeficiency. (This pattern is based on how other combined immunodeficiencies behave, not only on IMD16 case reports.)

3. Genetic pattern: homozygous vs. compound heterozygous
   At the DNA level, some patients have the same TNFRSF4 mutation on both copies of the gene (homozygous), while others have two different harmful mutations, one from each parent (compound heterozygous). Both patterns lead to loss of OX40 function and to the same general clinical picture, but the exact changes in the protein can differ.

Causes

1. TNFRSF4 (OX40) gene mutation
   The main cause of immunodeficiency type 16 is a harmful mutation in the TNFRSF4 gene, which codes for the OX40 receptor. This change stops the protein from working properly on activated T cells, and this directly causes the immune defect.

2. Autosomal recessive inheritance
   The disease follows an autosomal recessive pattern. This means the child must inherit one faulty copy of the gene from each parent. The parents are usually healthy “carriers” with one normal and one mutated copy, but the child with two mutated copies develops the disease.

3. Loss of OX40–OX40L signaling
   OX40 on T cells must bind to its partner OX40L (ligand) on other immune cells to give a “second signal” for full T-cell activation. When OX40 is missing or non-functional, this co-stimulatory signal is lost, so T cells cannot respond well or survive for a long time.

4. Failure of memory CD4+ T-cell formation
   The OX40 pathway is especially important for making memory CD4+ T cells, which remember past infections. In immunodeficiency type 16, the absence of OX40 leads to very poor formation and survival of these memory cells, so the body cannot “remember” viruses like HHV-8.

5. Reduction of memory B cells
   Studies in affected children show a decrease in memory B cells in the blood. These are the B cells that usually produce strong, quick antibody responses when a germ appears again. Without enough memory B cells, antibody-mediated immunity is weak.

6. Poor T-cell recall responses
   In laboratory tests, T cells from patients with IMD16 show poor recall responses when they are re-stimulated with antigens they have seen before. This confirms that the immune system cannot build and maintain normal “memory” against infections.

7. Impaired control of HHV-8 (Kaposi sarcoma virus)
   Because T-cell memory is weak, the immune system cannot keep human herpesvirus 8 under tight control. This allows the virus to persist and drive the growth of Kaposi sarcoma lesions in the skin and sometimes inside the body.

8. Aggressive Kaposi sarcoma in childhood
   The combination of HHV-8 infection and a defective immune system causes aggressive, childhood-onset Kaposi sarcoma, with many lesions and systemic spread. In this way, the tumor itself becomes part of the disease process caused by the underlying gene defect.

9. Consanguinity (parents related by blood)
   In very rare recessive diseases like IMD16, consanguinity (for example, marriage between cousins) can increase the chance that both parents carry the same TNFRSF4 mutation. This raises the risk that their child will inherit two copies and develop the disease.

10. Family history of early Kaposi sarcoma or unexplained immunodeficiency
    A family history of childhood Kaposi sarcoma or unexplained severe viral infections suggests that the same TNFRSF4 mutation may run in the family. This family background is an important causal clue for doctors to suspect IMD16.

11. Additional infections overwhelming a weak immune system
    While they do not cause the gene defect, repeated infections with viruses, bacteria, or fungi can make the immune weakness more obvious and worsen the person’s health. Each infection places stress on an already fragile immune system. This is a contributing factor, not the primary cause.

12. Delayed diagnosis and lack of early supportive care
    If the condition is not recognized early, a child may go for years with untreated infections and uncontrolled HHV-8, allowing Kaposi sarcoma to become more widespread. The delay does not create the gene defect, but it worsens outcomes by allowing disease processes to continue.

13. Malnutrition and poor general health
    Poor nutrition can further weaken immune defenses in a child who already has IMD16. Low protein or vitamin levels can reduce the production and function of immune cells, adding to the effect of the genetic defect. This is another modifying factor, not the root cause.

14. Cytotoxic chemotherapy for Kaposi sarcoma
    Some treatments used for Kaposi sarcoma, such as cytotoxic chemotherapy, can damage bone marrow and lymphocytes. In a patient whose immune system is already weak, this may deepen the immunodeficiency and increase infection risk.

15. Long-term steroid or immunosuppressive drug use
    If a person with IMD16 receives steroids or other immunosuppressive drugs for any reason, their already fragile immune system can become even weaker. This makes infections and tumors more likely and more severe.

16. Co-existing infections like HIV (differential, not causal)
    HIV infection can cause secondary immunodeficiency and Kaposi sarcoma, so it must be ruled out. While HIV does not cause immunodeficiency type 16, having both conditions would greatly worsen immune function and disease course. Doctors therefore test for HIV to separate and understand the causes of immune weakness.

17. Environmental exposure to pathogens (crowded living, poor sanitation)
    Living in crowded conditions with poor sanitation increases the number of times a person is exposed to infections. For someone with IMD16, this higher exposure may lead to more infections and complications, though again it does not create the gene mutation itself.

18. Chronic inflammation and tissue damage
    Repeated infections and tumor growth cause ongoing inflammation in tissues. Over time, this chronic inflammation can damage organs such as the lungs, liver, or lymphatic system, making the disease more severe and harder to control.

19. Emotional stress and poor sleep
    Stress and sleep loss do not change the TNFRSF4 gene, but they can make immune responses weaker in general. In someone with an inherited immunodeficiency, these lifestyle factors may further reduce resistance to infection and slow recovery.

20. Limited access to specialized immunology care
    Because the condition is rare, many regions do not have easy access to genetic testing or expert immunologists. Limited access delays correct diagnosis and appropriate monitoring, which indirectly causes worse outcomes and more complications in affected children.

Symptoms

1. Childhood-onset Kaposi sarcoma skin lesions
   The most characteristic symptom is the appearance of Kaposi sarcoma lesions in childhood. These may look like purple, red, or brown patches, plaques, or nodules on the skin. In IMD16, these lesions are often numerous and aggressive because the immune system cannot control HHV-8 well.

2. Widespread or disseminated skin involvement
   Instead of just a few spots, children may have lesions on many parts of the body. This widespread involvement signals that both the virus and the tumor are not being held in check by the immune system, which fits the pattern of a combined immunodeficiency.

3. Mucosal Kaposi lesions (mouth, gut, other organs)
   Lesions can also appear on the lining of the mouth, digestive tract, or other internal organs. These mucosal lesions can cause pain, trouble eating, or bleeding. Their presence shows that the disease is systemic, not only confined to the skin.

4. Swelling of limbs or body parts (lymphedema)
   Kaposi sarcoma and lymphatic involvement may block normal lymph flow, leading to swelling in legs, arms, or other areas. This swelling can be uncomfortable, can limit movement, and is often a visible sign that the disease is advanced.

5. Recurrent or severe viral infections
   Because T-cell memory is poor, patients may have repeated viral infections, such as herpes family viruses and other common childhood viruses. These infections may last longer, be more severe, or recur more often than in healthy children.

6. Recurrent bacterial infections (especially respiratory)
   Combined T- and B-cell problems can also lead to recurrent bacterial infections, especially in the lungs, ears, and sinuses. Children may have repeated episodes of pneumonia, bronchitis, or sinusitis that require antibiotics and hospital care.

7. Poor response to vaccines
   Because memory B cells and T cells are defective, the body may not respond properly to routine vaccines. The child might still get infections that the vaccine should have prevented, showing that the immune system cannot build strong protective memory.

8. Enlarged lymph nodes (lymphadenopathy)
   The lymph nodes, especially in the neck, armpits, or groin, may be enlarged. This can be due to infection, tumor spread, or both. Enlarged nodes are often found on physical exam and may prompt further testing.

9. Enlarged liver or spleen (hepatosplenomegaly)
   The liver and spleen may become enlarged due to chronic infection, tumor involvement, or immune activation. Doctors can feel this on abdominal exam, and it is often confirmed with imaging tests such as ultrasound.

10. Fever and night sweats
    Many patients experience fever due to infections or tumor activity. Night sweats may also occur, especially when the disease is active. These symptoms are non-specific but, together with other signs, support the picture of a serious systemic illness.

11. Weight loss and poor growth in children
    Repeated infections, chronic inflammation, and cancer all use a lot of the body’s energy. Children with IMD16 may lose weight or fail to grow as expected for their age. Poor appetite and difficulty eating due to mouth lesions also contribute to this problem.

12. Fatigue and reduced energy
    Ongoing illness often leads to fatigue. Children may be unusually tired, unwilling to play, or may tire quickly with normal activities. This is partly due to chronic disease and partly due to infections and anemia.

13. Chronic cough or breathing trouble
    If the lungs are affected by infections or by tumors in the chest, patients may have a chronic cough, shortness of breath, or wheezing. Doctors pay special attention to these symptoms because lung involvement can be serious.

14. Frequent hospital or clinic visits
    Because of recurrent infections and the need to monitor Kaposi sarcoma, patients with IMD16 may need frequent medical visits, hospital stays, and repeated tests. This pattern of repeated healthcare use is a practical sign of how serious and persistent the disease can be.

15. Emotional and social impact
    Living with a chronic, life-threatening disease in childhood can cause fear, sadness, and stress for both the child and the family. Frequent procedures, visible skin lesions, and hospital stays can affect school attendance, friendships, and overall quality of life.

Diagnostic tests

(A) Physical exam tests

1. Full general physical examination
   The first and most important step is a careful physical exam. The doctor checks height, weight, vital signs, and overall appearance. They look for signs of chronic disease such as thin body build, pale skin, fatigue, or poor growth. This broad view helps them decide whether a serious underlying problem, like immunodeficiency, is likely.

2. Detailed skin examination
   The doctor closely inspects the entire skin surface for purple, red, or brown patches, plaques, or nodules that could be Kaposi sarcoma. They note the number, size, and distribution of lesions and whether there is any ulceration or infection. This exam gives early clues that the patient may have IMD16 with Kaposi sarcoma.

3. Lymph node examination
   By feeling (palpating) the neck, armpits, groin, and other areas, the doctor looks for enlarged lymph nodes. They note the size, texture, and tenderness of the nodes. Firm, non-tender nodes or very widespread enlargement may suggest tumor involvement or chronic infection.

4. Abdominal examination for liver and spleen
   The doctor feels under the ribs on the right and left side to check for an enlarged liver or spleen. A big liver or spleen can reflect chronic infection, tumor spread, or immune activation, and it is common in serious immunodeficiency states.

5. Respiratory and cardiovascular examination
   Using a stethoscope, the doctor listens to the lungs for crackles, wheezes, or other abnormal sounds that suggest infection or fluid. They also listen to the heart and check breathing rate and oxygen levels. These findings help spot pneumonia or other lung problems, which are common in immunodeficiencies.

(B) Manual and bedside tests

6. Palpation for edema and limb swelling
   The doctor presses gently on swollen areas, such as legs or feet, to see if there is pitting edema (a dent remains after pressure). This can be due to lymphatic blockage from Kaposi sarcoma or from other causes. This simple manual test gives clues about how much the lymph system is affected.

7. Manual assessment of exercise tolerance
   Simple bedside tests, such as asking the child to walk a short distance or climb a few steps (if age-appropriate), help show how strong the lungs and heart are. If the child becomes very short of breath or tired, this suggests significant respiratory or systemic disease.

8. Neurological and muscle strength examination
   The doctor checks muscle strength, reflexes, and coordination with simple manual maneuvers. This can show whether there is nerve or muscle damage from long-term illness, chemotherapy, or infections that affect the nervous system.

9. Oral and mucosal inspection
   A careful manual exam of the mouth, tongue, gums, and throat helps detect Kaposi sarcoma lesions or other infections such as thrush. These findings can show how widespread the disease is and may explain problems with eating or swallowing.

10. Serial physical exams for disease progression
    Repeating the physical and manual exams over time is itself a kind of test. Changes in lesion number, lymph node size, or organ enlargement help doctors judge whether treatment is working or whether the disease is progressing.

(C) Laboratory and pathological tests

11. Complete blood count (CBC) with differential
    A CBC measures red cells, white cells, and platelets. In IMD16, the total lymphocyte count may be low or normal, but the CBC is essential to detect anemia, thrombocytopenia, or other changes that suggest chronic disease or side effects of treatment. The differential shows the relative numbers of neutrophils, lymphocytes, and other cells.

12. Lymphocyte subset analysis (flow cytometry)
    Flow cytometry separates lymphocytes into T cells, B cells, and NK cells, and can further identify memory and naïve subsets. In IMD16, there is a reduction in memory T cells and memory B cells, while some other subsets may be relatively preserved. This pattern confirms combined immunodeficiency and is a key test for diagnosis.

13. Serum immunoglobulin levels and specific antibody titers
    Blood tests measure total IgG, IgA, IgM, and sometimes IgE. Doctors also measure antibody levels to previous vaccines or infections. In IMD16, these levels may be low or show poor response, which reflects the defective memory B-cell function.

14. Functional T-cell proliferation tests
    In specialized labs, T cells are stimulated with mitogens or recall antigens, and their ability to divide is measured. Patients with IMD16 show poor recall responses, which confirms that T-cell memory is impaired even if baseline counts are not extremely low.

15. HHV-8 detection (PCR or serology)
    Tests for human herpesvirus 8, such as PCR (looking for viral DNA in blood or tissue) or antibody tests, help confirm infection with the virus that drives Kaposi sarcoma. A positive result, especially with high viral load, supports the link between the virus, the tumor, and the immunodeficiency.

16. HIV and other infection screening (differential diagnosis)
    Because HIV can also cause Kaposi sarcoma and severe immunodeficiency, every patient with Kaposi sarcoma and suspected immune weakness is usually tested for HIV and other chronic infections. A negative HIV test with positive signs of primary immunodeficiency makes a genetic cause like IMD16 more likely.

17. Biopsy and histopathology of skin or tissue lesions
    A small sample of a skin or mucosal lesion is taken and examined under the microscope. In Kaposi sarcoma, the pathologist sees characteristic spindle cells, abnormal blood vessel growth, and signs of HHV-8 infection. This confirms the diagnosis of Kaposi sarcoma, which is strongly linked to IMD16 in these children.

18. Genetic testing for TNFRSF4 (OX40) mutations
    The final, definitive test for immunodeficiency type 16 is genetic analysis of the TNFRSF4 gene. DNA sequencing can identify homozygous or compound heterozygous pathogenic variants. When this specific mutation pattern is found together with the clinical picture, doctors can firmly diagnose IMD16.

(D) Electrodiagnostic tests

19. Electrocardiogram (ECG) for treatment safety
    An ECG records the electrical activity of the heart. It is not specific for IMD16, but it is important to check heart rhythm and conduction before and during some chemotherapy drugs or other treatments that may stress the heart. In this way, ECG helps keep treatment safe in a patient with chronic disease.

20. Nerve conduction or electromyography (when indicated)
    In some cases, especially if the patient develops weakness, numbness, or other neurologic symptoms (for example, due to chemotherapy or infections), nerve conduction studies or electromyography may be done. These tests look at how well nerves and muscles work. They are not specific to IMD16 but help assess complications of long-term illness and treatment.

(E) Imaging tests (often used alongside the 20 tests above)

Although we have already counted 20 main tests, imaging is also very important. Doctors frequently use chest X-ray or CT scans to look for lung infections and chest tumors, abdominal ultrasound or CT to check the liver and spleen, and sometimes PET-CT to stage Kaposi sarcoma throughout the body. These imaging studies help map where the disease is and how well treatment is working, but they are usually interpreted together with the laboratory and physical exam findings described above.

Non-pharmacological treatments

1. Infection-prevention education for family
Teaching the child and family about hand washing, mask use during outbreaks, safe food handling, and how to recognize early signs of infection is a first, simple therapy. The purpose is to reduce contact with germs. The mechanism is basic: fewer germs reaching the child means fewer infections and less stress on their weak immune system. [3] [4]

2. Strict hand and respiratory hygiene
Daily habits such as washing hands with soap, using alcohol rub, covering coughs, and throwing tissues away quickly help stop bacteria and viruses spreading. The purpose is to cut transmission at the “entry gates” (nose, mouth, skin). The mechanism is mechanical removal of germs and blocking droplets before they reach mucosal surfaces. [3] [5]

3. Avoidance of crowded and high-risk places
Children with IMD16 are often advised to avoid crowded buses, markets, and waiting rooms during flu or other outbreaks. The purpose is to lower exposure to people who may be sick. The mechanism is simple risk reduction: fewer close contacts mean fewer chances to pick up respiratory viruses or other infections. [3] [6]

4. Safe food and water practices
Eating well-cooked food, avoiding raw eggs or unpasteurized milk, and drinking clean water helps prevent gut infections. The purpose is to block food-borne bacteria and parasites, which can be severe in immunodeficiency. The mechanism is removal or killing of microbes before they enter the intestine. [3] [7]

5. Dental and mouth care
Brushing teeth twice daily, flossing when appropriate, and regular dental checks help prevent gum infection and tooth decay, which can spread deeper in immune-weakened patients. The purpose is to keep the mouth as a low-germ environment. The mechanism is mechanical plaque removal and early treatment of small problems before they become serious infections. [3] [5]

6. Individualized school and social planning
School attendance may be adjusted (smaller classes, home schooling during outbreaks, vaccination checks for classmates) to balance normal life with safety. Purpose: keep education and social life while avoiding high infection risk. Mechanism: environmental control—fewer exposures to unwell peers. [3] [8]

7. Household and caregiver vaccination (cocooning)
Parents, siblings, and close carers are encouraged to receive inactivated vaccines (like flu and COVID-19 shots). Purpose: make a protective “shield” of immune people around the child. Mechanism: if contacts are less likely to get sick, they are less likely to pass germs to the child. Live vaccines in contacts are chosen carefully. [4] [9]

8. Avoidance of live vaccines in the patient
Children with combined T-cell defects like IMD16 generally should not receive live vaccines such as BCG or live oral polio, because they can cause disease in them. Purpose: prevent vaccine-strain infection. Mechanism: in the absence of strong T-cell responses, live vaccines can replicate too much, so doctors rely on inactivated vaccines where possible. [9] [10]

9. Early isolation and mask use during illness
If the child or a family member becomes sick, quick isolation in a room with good ventilation and use of masks can reduce spread. Purpose: stop one infection from “running through” the household. Mechanism: physical separation and reduced droplet spread. [3] [6]

10. Prompt wound and skin care
Any cut, rash, or insect bite should be cleaned and covered early. Purpose: prevent skin infections that may spread to blood in immunodeficiency. Mechanism: reducing bacterial load on the skin surface and closing the entry point with dressings. [3] [5]

11. Regular moderate exercise
Simple, supervised activities (walking, stretching, light play) can improve lung function, circulation, and mood. Purpose: support overall health without exhaustion. Mechanism: moderate exercise can enhance some immune functions and reduce stress hormones, but heavy, prolonged exertion is avoided. [3] [11]

12. Adequate sleep and stress reduction
Children with chronic illness often sleep badly. Good sleep routines and stress-management support (relaxation, play, counselling) help the immune system work better. Purpose: avoid stress-related immune suppression. Mechanism: better sleep and lower stress hormones support both innate and adaptive immune responses. [3] [11]

13. Nutrition counselling
A diet rich in energy, protein, vitamins, and minerals supports growth and immune cell repair. Dietitians can plan meals that fit local foods and the child’s preferences. Mechanism: supplying building blocks for immune cells, antibodies, and tissue repair. [3] [12]

14. Environmental control (mould, smoke, pollutants)
Avoiding second-hand smoke, damp rooms with mould, and heavy indoor pollution reduces lung irritation and infections. Purpose: keep airways healthy. Mechanism: less damage to airway lining and better ciliary function make it harder for germs to take hold. [3] [12]

15. Physiotherapy and breathing exercises
If the child has chronic chest infections or early bronchiectasis, chest physiotherapy and breathing exercises can help clear mucus. Purpose: keep lungs clear of secretions where bacteria can grow. Mechanism: physical mobilization of mucus and improved ventilation. [3] [4]

16. Psychological support and family counselling
Living with a rare immunodeficiency and cancer risk is stressful. Psychologists and social workers help families cope, plan, and stay adherent to therapy. Purpose: protect mental health and reduce treatment fatigue. Mechanism: counselling reduces anxiety and depression, which can also influence immune responses. [3] [11]

17. Genetic counselling for family members
Because IMD16 is autosomal recessive, brothers, sisters, and future children may be affected or carriers. Genetic counselling explains testing, risks, and family planning options. Mechanism: informed reproductive decisions and earlier diagnosis in relatives who may show subtle signs. [1] [2]

18. Regular specialist follow-up in an immunology center
Routine visits with an immunologist and often an oncologist or hematologist allow early detection of new infections, autoimmunity, or Kaposi sarcoma lesions. Purpose: catch problems early when they are easier to treat. Mechanism: periodic exams, imaging, and labs mean less delay between onset and treatment. [2] [3]

19. Sun-exposure management for Kaposi lesions
Kaposi sarcoma patches on skin may worsen with sun exposure. Using clothing, shade, and sunscreen can be part of care. Purpose: protect fragile skin and possibly reduce lesion irritation. Mechanism: less UV-induced inflammation and damage on already abnormal blood-vessel lesions. [6] [13]

20. Infection-control plans for hospital visits
When the child goes to hospital, staff may use special infection-control steps (fast-track admission, masks, separate waiting areas). Purpose: prevent hospital-acquired infections. Mechanism: reducing contact with other sick patients and following strict cleaning protocols. [3] [4]

---

Drug treatments

Important: Doses below are general patterns from product information. They are not personal prescriptions. A specialist must choose exact dose, schedule, and drug mix for each child.

1. Intravenous immune globulin (IVIG)
IVIG is pooled human antibodies given through a vein every 3–4 weeks to replace missing or weak antibodies in primary immunodeficiency. The purpose is to prevent serious bacterial infections and sometimes help control viruses. Dose is weight-based (g/kg) and adjusted to keep IgG levels high enough; common side effects are headache, fever, and infusion reactions. [4] [10]

2. Subcutaneous immune globulin (SCIG)
SCIG uses the same immunoglobulin but is injected under the skin in small, regular doses, often weekly. Purpose is similar to IVIG but allows home treatment and more steady IgG levels. Mechanism is slow absorption into blood from fat tissue; side effects are mostly local swelling and discomfort. [4] [10]

3. Trimethoprim–sulfamethoxazole (TMP-SMX)
TMP-SMX is a broad antibiotic often used as daily or intermittent prophylaxis against Pneumocystis, some bacteria, and sometimes as treatment for acute infections. Dose is weight-based, usually twice daily; mechanism is blocking bacterial folate synthesis at two steps. Side effects can include rash, low blood counts, and, rarely, severe skin reactions, so blood tests and allergy checks are important. [11] [12] [13]

4. Broad-spectrum beta-lactam antibiotics (for acute infections)
Drugs like third-generation cephalosporins or amoxicillin–clavulanate are used when serious bacterial infections occur. Purpose is to quickly treat sepsis, pneumonia, or severe sinus/ear infections. They work by blocking bacterial cell-wall synthesis. Doses are adjusted to infection site and kidney function; side effects include allergy, diarrhea, and C. difficile infection. [3] [4]

5. Acyclovir
Acyclovir is an antiviral used to treat or prevent herpesvirus infections; in IMD16, it may be considered to help control herpes simplex or varicella and sometimes HHV-8, though data are limited. It is a nucleoside analogue that stops viral DNA replication. Doses are weight-based, oral or IV; side effects include kidney strain and neurotoxicity at high levels, so hydration and dose adjustment are key. [14] [15] [16]

6. Ganciclovir or valganciclovir
These antivirals may be used if there is cytomegalovirus (CMV) disease or high viral load. They are stronger nucleoside analogues that block viral DNA polymerase. Purpose is to prevent organ damage from CMV; side effects include bone-marrow suppression (low blood counts) and kidney toxicity, so monitoring blood tests is essential. [6] [13]

7. Liposomal doxorubicin
Pegylated liposomal doxorubicin is a chemotherapy drug used for advanced Kaposi sarcoma, including AIDS-related cases and sometimes classic KS. It intercalates into DNA and generates free radicals to kill tumor cells, with liposomes helping target tissue and reduce some toxicity. Doses are mg/m² every few weeks; side effects include heart damage risk, low blood counts, mucositis, and infusion reactions, so cardiac monitoring is vital. [6] [7] [17]

8. Paclitaxel
Paclitaxel is another chemotherapy used for Kaposi sarcoma when anthracyclines are not suitable or have failed. It stabilizes microtubules and stops cell division. Given IV every 2–3 weeks, it can shrink KS lesions but causes hair loss, neuropathy, and bone-marrow suppression, so close monitoring and infection prophylaxis are needed. [6] [18]

9. Vincristine
Vincristine is part of some Kaposi sarcoma regimens (for example with bleomycin and doxorubicin). It blocks microtubule formation during mitosis, slowing tumor growth. It is given IV once weekly or in cycles; side effects include nerve damage (tingling, weakness), constipation, and low platelets. [6]

10. Bleomycin
Bleomycin is another chemotherapy sometimes used in combination regimens for KS. It induces DNA strand breaks. Dosing is based on body surface area and cumulative lifetime dose due to lung toxicity. Side effects include pulmonary fibrosis risk and skin changes, so doctors limit dose and monitor lung function. [6]

11. Interferon-alpha
Interferon-alpha is an immune signalling protein sometimes used in Kaposi sarcoma and chronic viral infections. It aims to boost antiviral and anti-tumor responses. It is given by injection several times per week; side effects include flu-like symptoms, mood changes, and bone-marrow suppression. In IMD16, its use must be very carefully balanced with already fragile immunity. [6] [13]

12. Azithromycin or other macrolides (prophylaxis)
Macrolide antibiotics may be used as prophylaxis for certain respiratory or atypical infections, based on local patterns. They block bacterial protein synthesis and also have some anti-inflammatory effects. Once-daily or three-times-weekly regimens are used; side effects include stomach upset and rare heart-rhythm changes. [4] [8]

13. Fluconazole or similar antifungals
In patients with repeated fungal infections (thrush, esophagitis, candidemia), oral or IV fluconazole may be given prophylactically or as treatment. It inhibits fungal ergosterol synthesis, weakening cell membranes. Doses are weight-based once daily; side effects include liver enzyme rise and drug interactions, so monitoring is needed. [4] [28]

14. Broad-spectrum antivirals in trials (for HHV-8 control)
Some centers may consider enrolment in clinical trials of antivirals or targeted agents aiming at HHV-8 or its pathways. The purpose is better control of the virus that drives Kaposi sarcoma. Mechanisms vary by agent (e.g., nucleoside analogues, kinase inhibitors). Use is experimental and strictly supervised. [6] [13]

15. Granulocyte-colony stimulating factor (G-CSF)
If chemotherapy or infections cause severe neutropenia, G-CSF like filgrastim may be used to stimulate bone marrow to produce neutrophils. It binds G-CSF receptors on precursor cells. Doses are small daily injections until counts recover; side effects include bone pain and rare spleen enlargement. [11] [19]

16. Antiemetics (supportive drugs)
When chemotherapy is used, anti-nausea drugs such as 5-HT3 antagonists help maintain nutrition and treatment adherence. They block serotonin receptors in the gut and brain. Doses follow standard oncology protocols; side effects are usually mild headaches or constipation. [6]

17. Antipyretics (paracetamol/acetaminophen)
Used carefully to manage fever and discomfort, antipyretics reduce prostaglandin production in the brain to lower temperature set-point. They improve comfort but can mask infection, so use is always combined with close medical review. Overdose risks liver toxicity, so dose must follow weight-based guidance. [3] [19]

18. Broad-spectrum intravenous antibiotics for sepsis
In life-threatening sepsis, combinations such as a beta-lactam plus aminoglycoside or anti-MRSA agent may be needed. They act on different bacterial targets to provide rapid coverage. Dosing is intensive and guided by cultures; side effects include kidney injury and ototoxicity, so hospital monitoring is essential. [3] [4]

19. Topical therapies for skin Kaposi lesions
Topical retinoids (such as alitretinoin gel) or local chemotherapy can be used for limited skin KS. They act by influencing cell proliferation and differentiation. They are applied directly to lesions; side effects include local irritation and redness. [6] [13]

20. Pain-control medicines
When lesions, procedures, or infections are painful, simple analgesics (paracetamol, sometimes opioids under specialist control) are used. Purpose is to improve quality of life and help the child move and breathe deeply. Mechanism is blocking pain pathways in the nervous system. Doses are carefully adjusted to age and kidney/liver function. [3] [19]

---

Dietary molecular supplements

Supplements must always be checked with the child’s specialist to avoid interactions or toxicity.

1. Vitamin D
Vitamin D helps regulate both innate and adaptive immunity and may lower risk of respiratory infections in deficient people. It works through nuclear receptors on immune cells that change gene expression. Doses depend on blood levels (often daily or weekly cholecalciferol); too much can cause high calcium and kidney problems. [20] [21] [22] [23] [24]

2. Zinc
Zinc is essential for many enzymes and for T-cell and B-cell function. Lack of zinc clearly increases infection risk. Supplements usually provide up to the recommended upper limit (not more than about 40 mg/day in adults, adjusted for children) to avoid copper deficiency and other harms. [25] [26] [27] [28]

3. Vitamin C
Vitamin C supports antioxidant defence and normal function of skin and immune cells. It helps maintain the physical barriers and may slightly shorten common cold duration in some groups. Doses are usually modest daily intakes from diet or low-dose supplements; very high doses can cause stomach upset and kidney stones. [19] [27]

4. Selenium
Selenium is part of antioxidant enzymes and may influence viral immunity. Deficiency is linked with worse outcomes in some viral illnesses. Supplement doses are small (microgram range) and must stay below upper safe limits to avoid hair and nail problems or toxicity. [21] [28]

5. Omega-3 fatty acids
Omega-3 fats from fish oil or algae can reduce inflammation and may support cardiovascular health in chronic illness. They act by changing membrane lipids and mediators like prostaglandins and resolvins. Usual doses are a few hundred milligrams of EPA/DHA per day; side effects can be fishy taste and, at high dose, bleeding tendency. [19]

6. Probiotics
Selected probiotic strains modestly reduce the number and duration of respiratory infections in children and adults in several trials. They act by balancing gut microbiota and influencing gut–immune signalling. Doses depend on product (often billions of CFU daily). In severe immunodeficiency, probiotics must be chosen carefully and used under medical supervision. [29] [30] [31] [32]

7. Beta-glucans (from yeast or mushrooms)
Beta-glucans are polysaccharides that can modulate activity of macrophages and natural killer cells. Some studies show immune-modulating and fatigue-reducing effects; others show little benefit, so evidence is mixed. Doses vary by product. They should be seen as an experimental adjunct, not a proven therapy. [33] [34] [35]

8. Protein and amino acid supplements
If a child cannot meet protein needs through food, oral supplements ensure enough amino acids for immune cell growth and tissue healing. They work simply as building blocks for antibodies and cytokines. Doses are tailored by dietitians based on weight and kidney function. [19] [35]

9. Multivitamin–mineral preparations
A basic multivitamin may help cover small gaps in diet. Its mechanism is broad support of many enzyme systems. It should respect age-specific daily recommended amounts and avoid “mega doses.” [19] [27]

10. Iron (only if deficient)
Iron is needed for red blood cells and some immune processes, but excess iron can promote bacterial growth. Supplementation is only used if blood tests confirm deficiency. Doses and forms (oral or IV) are selected carefully, and side effects include stomach upset and dark stools. [19] [31]

---

Immunity-booster, regenerative and stem-cell–related drugs

1. Hematopoietic stem cell transplantation (HSCT) conditioning and graft
For some combined immunodeficiencies, HSCT can offer a chance of cure by replacing the faulty immune system with donor stem cells. The “drug” here is the stem cell graft plus conditioning chemotherapy. The mechanism is engraftment of healthy donor stem cells that make normal T- and B-cells. Survival in modern PID HSCT often exceeds 80% in experienced centers, but risks remain. [11] [36] [37] [38]

2. Autologous gene-therapy–modified stem cells (research stage for IMD16)
Gene therapy for inborn errors of immunity takes the patient’s own stem cells, corrects the faulty gene in the lab, and returns them. For IMD16 this is theoretical, but similar methods are already used in other primary immunodeficiencies. The mechanism is gene addition or editing using viral vectors or CRISPR tools. [12] [39]

3. G-CSF during stem cell mobilisation
Before some gene therapies or donor collections, G-CSF can be used to mobilize stem cells into the blood. It stimulates bone marrow progenitors via G-CSF receptors. Doses and timing are short and supervised; side effects include bone pain and rare splenic rupture, so ultrasound and clinical checks are important. [11] [36]

4. Thymic-supportive or immune-modulating peptides (e.g., thymosin alpha-1, experimental)
Some centers explore thymic peptides to support T-cell recovery in immunodeficiency or after HSCT. They may act by improving T-cell maturation and function. Evidence is limited, so they are usually used only in research or special cases. [11] [39]

5. Cytokine therapies (e.g., low-dose interleukins in trials)
Experimental use of cytokines, such as interleukin-2, aims to boost specific T-cell subsets. These drugs interact with cytokine receptors to drive cell proliferation and activation. Because of serious potential side effects (fever, capillary leak, autoimmunity), they are confined to clinical trials. [39]

6. Mesenchymal stromal cell products (for complications, in trials)
Mesenchymal stromal cells are being studied to treat graft-versus-host disease and severe inflammation after HSCT. They work by releasing anti-inflammatory and tissue-repair mediators. Use is strictly in specialist centers as part of advanced therapies. [37] [39]

---

Surgeries and invasive procedures

1. Diagnostic and therapeutic biopsy of Kaposi lesions
Skin or lymph-node biopsy confirms Kaposi sarcoma and helps rule out other cancers. If lesions are small, surgery can also remove them. The purpose is accurate diagnosis and sometimes local control. [6] [13]

2. Surgical excision of isolated skin lesions
For limited, localized lesions that cause pain or bleeding, surgical removal can provide good cosmetic and symptomatic relief. Mechanism is simple physical removal of tumor tissue, often combined with other therapies if new lesions appear. [6]

3. Central venous catheter placement
Children who need frequent IVIG infusions, chemotherapy, or antibiotics often require a central line or port. This procedure makes treatment easier and less painful. The mechanism is secure long-term venous access, but it carries infection and clot risks, so strict catheter care is essential. [3] [4]

4. Debulking or laser therapy of oral or airway lesions
If Kaposi lesions affect the mouth, throat, or airway, ENT surgeons may use surgery or laser to debulk them and maintain breathing and swallowing. Purpose is symptom control and prevention of obstruction. [6] [17]

5. Hematopoietic stem cell transplantation (HSCT) procedure itself
HSCT is both a treatment and a major procedure. It involves conditioning chemotherapy, infusion of stem cells, and long hospital stay in protective isolation. The goal is long-term re-building of the immune system; the risks include infection, graft-versus-host disease, and organ toxicity. [11] [36] [37]

---

Preventions

1. Early diagnosis and family screening
Recognizing IMD16 or other primary immunodeficiencies early and testing at-risk siblings allows earlier start of protective measures, immunoglobulin, and cancer surveillance. [1] [2]

2. Avoidance of live vaccines in affected children
As noted, not giving live BCG, oral polio, or other live vaccines prevents vaccine-related infection in T-cell defects. [9]

3. Up-to-date inactivated vaccines (where safe)
Inactivated flu, pneumococcal, and COVID-19 vaccines may still give some protection and are usually recommended unless the specialist advises otherwise. [4] [9]

4. Household vaccination and infection control
Vaccinating and educating family members creates a protective bubble and lowers introduction of viruses like flu and COVID-19 into the home. [3] [9]

5. Long-term immunoglobulin replacement where indicated
Regular IVIG or SCIG is a key preventive tool to reduce severe bacterial infections in many primary immunodeficiencies. [4] [10]

6. Prophylactic antibiotics in high-risk patients
Low-dose antibiotics like TMP-SMX can prevent Pneumocystis and some bacterial infections when guided by local protocols and individual risk assessment. [11]

7. Careful travel planning
Avoiding high-risk travel destinations, getting medical letters, and arranging local medical contacts reduce emergency risks. [3]

8. Regular cancer surveillance for Kaposi sarcoma
Routine skin, oral, and lymph-node checks help detect new KS lesions early, when local treatments or early systemic therapy are more effective. [6] [13]

9. Healthy lifestyle (diet, exercise, no smoking)
Balanced food, gentle activity, and avoiding tobacco smoke support lungs and immune system and lower other chronic disease risks. [3] [19]

10. Emergency plans for fever or new symptoms
Families should have clear written plans: who to call, where to go, and when to start urgent antibiotics if advised by the immunology team. This avoids dangerous delays in sepsis or severe infection. [3] [28]

---

When to see doctors (or go to emergency)

Children with IMD16 should see their immunologist regularly even when they feel well, for check-ups, lab tests, and review of growth, infections, and any new skin lesions. Any fever, new rash, mouth ulcers, breathing trouble, persistent cough, weight loss, night sweats, or new purple-red skin spots that might be Kaposi sarcoma need rapid assessment. Parents are usually told to seek emergency care the same day for high fever, breathing difficulty, confusion, very low energy, or poor drinking and urination, because sepsis can progress quickly in primary immunodeficiency. [2] [3] [6]

---

What to eat and what to avoid

1. Eat a balanced diet with enough calories, protein, fruits, and vegetables to support growth and immune function. [19]

2. Eat cooked meats, fish, and eggs; avoid undercooked or raw animal products to reduce food-borne infections. [7]

3. Eat safe dairy (pasteurized milk, yogurt, cheese) and avoid unpasteurized dairy products. [7]

4. Eat foods rich in zinc and vitamins (beans, lentils, nuts if safe, whole grains, eggs, meat, fruits, vegetables) to support immune cells. [25] [26]

5. Drink plenty of safe water; avoid untreated surface water or questionable drinks. [7]

6. Avoid street food or buffets where food may sit at room temperature for long times. [7]

7. Avoid extreme “immune booster” diets or high-dose supplements not approved by the treating team, because some can be harmful. [20] [21]

8. Limit sugary drinks and ultra-processed snacks that replace nutrient-dense food. [19]

9. Avoid alcohol and smoking exposure; these worsen infection risk and organ damage. [19]

10. Work with a dietitian if the child is underweight, has poor appetite, or has mouth sores that make eating painful. [3]

---

Frequently asked questions

1. Is immunodeficiency type 16 the same as HIV?
No. IMD16 is an inborn error of immunity caused by changes in the TNFRSF4 (OX40) gene, present from birth. HIV is an acquired viral infection. Both can lead to Kaposi sarcoma and serious infections, but their causes and treatments differ. [1] [2]

2. Can IMD16 be cured?
There is no simple medicine that “switches off” IMD16. In some combined immunodeficiencies, hematopoietic stem cell transplantation can rebuild the immune system and may offer long-term remission or cure, but experience in IMD16 specifically is very limited and decisions are highly individual. [11] [36]

3. Will every child with IMD16 develop Kaposi sarcoma?
No, but the known patients had childhood-onset classic Kaposi sarcoma, showing that risk is high. Close skin and systemic monitoring is therefore important to catch lesions early and treat them. [1] [6]

4. Why is immunoglobulin replacement so important?
Even though IMD16 is mainly a T-cell problem, antibodies can also be affected. Immunoglobulin replacement helps prevent repeated bacterial infections and improves quality of life, and is a standard of care in many primary immunodeficiencies. [4] [10]

5. Are live vaccines always unsafe?
In significant T-cell defects like IMD16, live vaccines are generally avoided because they can cause disease. However, family members are usually encouraged to fully vaccinate (with appropriate products) to protect the child. Decisions are taken by the immunologist case by case. [9]

6. Can diet alone fix IMD16?
No diet can correct the missing OX40 function. However, good nutrition can reduce complications, help the child grow, and support remaining immune function. Diet is a support, not a cure, and should be combined with medical treatments. [3] [19]

7. Are “immune booster” supplements safe?
Some supplements (vitamin D, zinc) are useful when there is deficiency, but high doses can be harmful. Others, like certain herbal products, may interact with chemotherapy or immunosuppressive drugs. Always discuss any supplement with the specialist team first. [20] [25] [28]

8. Can children with IMD16 go to school?
Many can, with adjustments. Plans may include vaccination checks for classmates, good hygiene, and home learning during major outbreaks. The goal is to balance normal development with infection safety. [3] [8]

9. What is the long-term outlook?
Because IMD16 is extremely rare, long-term data are scarce. Outcomes depend on infection control, cancer management, and access to specialist care. With improved diagnostics, prophylaxis, and treatments, survival and quality of life in many primary immunodeficiencies have improved over recent decades. [2] [11]

10. Can siblings be tested?
Yes. Genetic testing of siblings is important to find affected children early and to identify carriers. This helps with planning and early prophylaxis or treatment if needed. [1] [2]

11. Is pregnancy possible later in life?
Some individuals with primary immunodeficiency can have successful pregnancies with close monitoring by obstetricians and immunologists. However, specific data for IMD16 are lacking, and genetic counselling is needed to discuss inheritance risks and management. [2] [31]

12. What specialists should be involved in care?
Care usually involves an immunologist, pediatrician, sometimes an oncologist/hematologist (for Kaposi sarcoma), infectious disease specialist, dietitian, psychologist, and transplant team if HSCT is considered. This team approach is key in rare, complex disorders. [2] [3]

13. Are there patient support groups?
Primary immunodeficiency organizations and rare-disease networks offer information, peer support, and help with navigating care and research. Families can be linked through national PID groups and rare-disease alliances. [3] [35]

14. Can new therapies appear in the future?
Yes. Advances in gene therapy, safer HSCT protocols, targeted antivirals, and immunotherapies are rapidly developing for many inborn errors of immunity and Kaposi sarcoma. Families should ask their specialists about clinical trials appropriate to their region and situation. [12] [39]

15. Is this information a substitute for medical care?
No. This summary is educational and cannot replace evaluation by qualified doctors. Any decisions about investigation, medication, diet, or surgery for IMD16 must be made with the child’s own medical team, based on their full history, tests, and local guidelines. [3] [19]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: February 14, 2025.